Home Cart Sign in  
Chemical Structure| 1700637-55-3 Chemical Structure| 1700637-55-3

Structure of CD38 inhibitor 1
CAS No.: 1700637-55-3

Chemical Structure| 1700637-55-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CD38 inhibitor 1 is a potent CD38 inhibitor with IC50 values of 7.3 nM and 1.9 nM for hCD38 and mouse CD38, respectively.

Synonyms: CD38-IN-78c; compound 78c; CD38 Inhibitor 78c

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CD38 inhibitor 1

CAS No. :1700637-55-3
Formula : C22H27N3O3S
M.W : 413.53
SMILES Code : COCCO[C@H](CC1)CC[C@@H]1NC2=CC(N(C)C3=CC=C(C=C32)C4=CN=CS4)=O
Synonyms :
CD38-IN-78c; compound 78c; CD38 Inhibitor 78c
MDL No. :MFCD32062812
InChI Key :VJQALSOBHVEJQM-UHFFFAOYSA-N
Pubchem ID :118736856

Safety of CD38 inhibitor 1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

Description
CD38 inhibitor 1 is a highly potent inhibitor of CD38, with IC50s of 7.3 nM and 1.9 nM for hCD38 and mouse CD38, respectively [1].

In Vitro:

Cell Line
Concentration Treated Time Description References
GD2-CD28z CAR-T cells 10 μM 72 hours To evaluate the effect of CD38 inhibition on CAR-T cell differentiation and function, results showed CD38 inhibitors promote central memory cell formation and reduce exhaustion marker expression. PMC10897548
CD19-41BBz CAR-T cells 10 μM 72 hours To evaluate the effect of CD38 inhibition on CAR-T cell differentiation and function, results showed CD38 inhibitors promote central memory cell formation and reduce exhaustion marker expression. PMC10897548
CD4+ T cells 10 μM 12 h Inhibited Th17 cell differentiation by modulating protein acetylation PMC10518596
Limb bud-derived mesenchymal cells 100 nM or 1 μM 14 days To explore the effects of CD38 inhibition on chondrogenic differentiation, results showed that 78c treatment significantly increased the formation of Alcian Blue-positive chondrogenic nodules. PMC9087467

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Unilateral ureteral obstruction (UUO) model Oral gavage 200 μg/mouse/day Six consecutive days, once daily CD38 inhibition significantly restored NAD+ levels in obstructed kidneys and ameliorated obstruction-induced renal fibrosis, partially through mechanisms involving reduced immune cell recruitment and NF-κB signaling. PMC10025283
C57BL/6 mice Destabilization of the medial meniscus (DMM) model Intra-articular injection 6 μg/knee joint Four times a week for 6 weeks To evaluate the protective effect of CD38 inhibitor on cartilage degradation in DMM-induced experimental mice, results showed that 78c treatment significantly reduced cartilage degeneration and subchondral bone sclerosis. PMC9087467

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.42mL

0.48mL

0.24mL

12.09mL

2.42mL

1.21mL

24.18mL

4.84mL

2.42mL

References

 

Historical Records

Categories